IBDEI251 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35874,1,4,0)
 ;;=4^O36.1114
 ;;^UTILITY(U,$J,358.3,35874,2)
 ;;=^5016897
 ;;^UTILITY(U,$J,358.3,35875,0)
 ;;=O36.1115^^166^1827^24
 ;;^UTILITY(U,$J,358.3,35875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35875,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 5
 ;;^UTILITY(U,$J,358.3,35875,1,4,0)
 ;;=4^O36.1115
 ;;^UTILITY(U,$J,358.3,35875,2)
 ;;=^5016898
 ;;^UTILITY(U,$J,358.3,35876,0)
 ;;=O36.1120^^166^1827^25
 ;;^UTILITY(U,$J,358.3,35876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35876,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, unsp
 ;;^UTILITY(U,$J,358.3,35876,1,4,0)
 ;;=4^O36.1120
 ;;^UTILITY(U,$J,358.3,35876,2)
 ;;=^5016900
 ;;^UTILITY(U,$J,358.3,35877,0)
 ;;=O36.1121^^166^1827^26
 ;;^UTILITY(U,$J,358.3,35877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35877,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 1
 ;;^UTILITY(U,$J,358.3,35877,1,4,0)
 ;;=4^O36.1121
 ;;^UTILITY(U,$J,358.3,35877,2)
 ;;=^5016901
 ;;^UTILITY(U,$J,358.3,35878,0)
 ;;=O36.1122^^166^1827^27
 ;;^UTILITY(U,$J,358.3,35878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35878,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 2
 ;;^UTILITY(U,$J,358.3,35878,1,4,0)
 ;;=4^O36.1122
 ;;^UTILITY(U,$J,358.3,35878,2)
 ;;=^5016902
 ;;^UTILITY(U,$J,358.3,35879,0)
 ;;=O36.1123^^166^1827^28
 ;;^UTILITY(U,$J,358.3,35879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35879,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 3
 ;;^UTILITY(U,$J,358.3,35879,1,4,0)
 ;;=4^O36.1123
 ;;^UTILITY(U,$J,358.3,35879,2)
 ;;=^5016903
 ;;^UTILITY(U,$J,358.3,35880,0)
 ;;=O36.1124^^166^1827^29
 ;;^UTILITY(U,$J,358.3,35880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35880,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 4
 ;;^UTILITY(U,$J,358.3,35880,1,4,0)
 ;;=4^O36.1124
 ;;^UTILITY(U,$J,358.3,35880,2)
 ;;=^5016904
 ;;^UTILITY(U,$J,358.3,35881,0)
 ;;=O36.1125^^166^1827^30
 ;;^UTILITY(U,$J,358.3,35881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35881,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 5
 ;;^UTILITY(U,$J,358.3,35881,1,4,0)
 ;;=4^O36.1125
 ;;^UTILITY(U,$J,358.3,35881,2)
 ;;=^5016905
 ;;^UTILITY(U,$J,358.3,35882,0)
 ;;=O36.1130^^166^1827^31
 ;;^UTILITY(U,$J,358.3,35882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35882,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, third tri, unsp
 ;;^UTILITY(U,$J,358.3,35882,1,4,0)
 ;;=4^O36.1130
 ;;^UTILITY(U,$J,358.3,35882,2)
 ;;=^5016907
 ;;^UTILITY(U,$J,358.3,35883,0)
 ;;=O36.1131^^166^1827^32
 ;;^UTILITY(U,$J,358.3,35883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35883,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, third tri, fetus 1
 ;;^UTILITY(U,$J,358.3,35883,1,4,0)
 ;;=4^O36.1131
 ;;^UTILITY(U,$J,358.3,35883,2)
 ;;=^5016908
 ;;^UTILITY(U,$J,358.3,35884,0)
 ;;=O36.1132^^166^1827^33
 ;;^UTILITY(U,$J,358.3,35884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35884,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, third tri, fetus 2
 ;;^UTILITY(U,$J,358.3,35884,1,4,0)
 ;;=4^O36.1132
 ;;^UTILITY(U,$J,358.3,35884,2)
 ;;=^5016909
 ;;^UTILITY(U,$J,358.3,35885,0)
 ;;=O36.1133^^166^1827^34
 ;;^UTILITY(U,$J,358.3,35885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35885,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, third tri, fetus 3
 ;;^UTILITY(U,$J,358.3,35885,1,4,0)
 ;;=4^O36.1133
 ;;^UTILITY(U,$J,358.3,35885,2)
 ;;=^5016910
 ;;^UTILITY(U,$J,358.3,35886,0)
 ;;=O36.1134^^166^1827^35
 ;;^UTILITY(U,$J,358.3,35886,1,0)
 ;;=^358.31IA^4^2
